Date of filling in this questionnaire or last update: 18/03/2021
1. IDENTIFICATION & BASIC DESCRIPTION
Cohort name
  BAMSE
Country
 

  • Sweden

Please provide any other information on the cohort location/s if needed
  Stockholm
Name
  Erik Melén
Institution
  Karolinska Institutet
Email
  erik.melen@ki.se
Phone
  +46-(0)8-524 875 08
Personal website
  https://staff.ki.se/people/erimel
Name
  Antonios Georgelis
Institution
  Center for Occupational and Environmental medicine, Region Stockholm, Sweden
Email
  antonios.georgelis@sll.se
Website
 

  • www.ki.se/bamse

Name of committee
  Swedish Ethical Review Authority
Upload files
 

Contact Principal Investigator (name)
  Erik Melén
Is this cohort part of a consortium? (name consortium)
  MeDALL
Participation in pooled analyses
 

  • The cohort is potentially interested in participating in pooled analyses of (European) occupational cohort studies (note pooled analyses also includes remote decentralized analyses that would not require any transfer of primary data as well as meta-analyses).

Main aim of cohort, please briefly describe the main objectives of the cohort
  BAMSE stands for children, allergy, environment, Stockholm and epidemiology (the Swedish words barn, allergi, miljö, Stockholm and epidemiologi) and is a collaborative project between Karolinska Institutet and Region Stockholm. The original aim of the project was to study the impact of environmental factors for the development of allergic diseases.
Study design (please select as many as appropriate)
 

  • Prospective cohort

Source population (please select as many as appropriate)
 

  • General population: Regional

Comparators (please select as many as appropriate)
 

  • Internal study population

Inclusion criteria
  All children born in certain areas of northern and central Stockholm between Feb 1994 and Nov 1996
Exclusion criteria
  the family planned to move within 1 year of the study start; insufficient knowledge of the Swedish language; the family had a seriously ill child; or an older sister or brother was already included in the study.
Enrollment
  Completed
Age range at entry (main cohort)
 

Minimum Maximum Mean
2-3 months 2-3 months 2-3 months

Men at enrollment
  0
Women at enrollment
  0
Children (<18 years) at enrollment
  4089
Men at last follow-up
  1445
Women at last follow-up
  1619
Children (<18 years) at last follow-up
  0
Participation rate at enrollment (if known)
  75
2. OUTCOME FOLLOW-UP
Type of data for outcome follow-up (please select as many as appropriate)
 

  • Active (contact with participants)

Active (contact with participants) (specify)
 

  • Questionnaires

First follow-up period (provide year)
  1
Last follow-up period (provide year)
  24
Number of follow-ups after baseline (provide number)
  7
Participation at last follow-up (if known)
  75
3. OCCUPATIONAL EXPOSURES
Source of exposure data collected (please select as many as appropriate)
 

  • Questionnaire, Personal (Self-reporting or interview)

Occupational history/time frame
  Current, at enrollment
Occupational coding performed
  Yes
Occupation (specify coding system used)
 

  • NYK codes
  • ISCO88 codes

Methods for exposure assessment (please select as many as appropriate)
 

  • Job Exposure Matrix

4. OUTCOMES EVALUATED
Baseline - type of outcome data collected (select more than one if applicable)
 

  • Questionnaire, individual (self-recording or interview)
  • Registry-based

Registry-based
 

  • Birth register

Follow-up - type of outcome data collected (select more than one if applicable)
 

  • Biomarker (specify)
  • Clinical/functional evaluation, e.g. spirometry, ECGs (specify)
  • Questionnaire, individual (self-recording or interview)
  • Registry-based

Specify: Clinical/functional evaluation, e.g. spirometry, ECGs
  Spirometry, blood samples etc in the offspring
Specify: Biomarker
  Urinary metabolites
Registry-based
 

  • Medication usage

Outcome type (please select as many as appropriate)
 

  • Morbidity

Diagnostic groups based on ICD10
 

  • J Respiratory disease

J Respiratory disease
 

  • Asthma

5. BIOLOGICAL SAMPLES & ANALYSIS
Biological samples collected
 

  • Blood
  • Urine

Biological processing
 

  • DNA
  • RNA

Genetic and other lab analyses
 

  • Biomarkers (specify)
  • Epigenomics
  • Genomics / GWAS
  • Metabolomics
  • Proteomics
  • Transcriptomics

Specify: Biomarkers
  urinary environmental pollutants, OLINK inflammation panel, plasma fatty acids
6. Other Information
 

  • Alcohol
  • Anthropometry
  • Demographics
  • Diet
  • Education
  • Environmental, air pollution
  • Environmental other (specify)
  • Medical history
  • Physical exercise
  • Residential history
  • Socioeconomic status
  • Smoking

Specify: Environmental other
  Noise
Possibility for linkage to data registries/data enrichment via data linkage
 

  • Birth register
  • Medication usage